| J0585 | Injection, onabotulinumtoxina, 1 unit | 20,850 | $10 | $104.2K |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 7,700 | $10 | $100.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 230 | $100 | $22K |
| 64615 | The provider bilaterally administers a chemical compound to the muscles innervated by the trigeminal, facial, cervical spinal, and accessory nerves. The goal of this procedure is to paralyze the… | 100 | $120 | $12.8K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 90 | $140 | $12.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 50 | $140 | $7.5K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 40 | $170 | $6.3K |
| 64616 | The provider administers a chemical compound to the neck muscles on one side, avoiding the laryngeal muscles. The goal of this procedure is to paralyze the muscles. Providers may treat cervical… | 20 | $110 | $2.3K |
| 99291 | Critical care services include the treatment of vital organ failure or prevention of further life–threatening conditions. Delivering medical care in a moment of crisis and in time of emergency is… | 10 | $180 | $2.1K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 20 | $100 | $1.9K |